Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster
The Motley Fool
MAY 23, 2024
Eli Lilly (NYSE: LLY) can't stop grabbing headlines. The pharmaceutical company has made quite a bit of noise over the past few years thanks to notable clinical and regulatory progress. Investors have rewarded the drugmaker accordingly -- Eli Lilly's shares have vastly outperformed the broader market in recent years. But the company is still hungry.
Let's personalize your content